Skip to content

Charcot Marie Tooth Disease Type 4d C1832334

Published: July 22, 2026Updated: August 20, 2026

An inherited nerve disorder linked to GDAP1 gene changes. It damages peripheral nerves, causing progressive muscle weakness and sensory loss. Management includes rehabilitation and assistive devices.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Distal muscle weakness

(neurologic)

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Gait disturbance

(neurologic)

Decreased deep tendon reflexes

(neurologic)

Upper limb involvement

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive Physical Therapy Program

Long-term physical therapy focusing on gait training, balance exercises, and strength preservation. Includes respiratory exercises as this subtype may involve vocal cord dysfunction and respiratory weakness.

physical_therapy
2

Drug therapy and clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Respiratory Function Surveillance

Regular monitoring of pulmonary function including vital capacity measurements and overnight oximetry to detect respiratory muscle weakness early. May require intervention with non-invasive ventilation if needed.

monitoring

Additional treatment options

Corrective Orthopedic Interventions

Surgical management of severe pes cavus deformity and potential scoliosis through osteotomies, arthrodesis procedures, and spinal instrumentation as needed to maintain ambulation and functional posture.

surgical

Pain and Symptom Pharmacotherapy

Management of neuropathic pain, muscle cramps, and discomfort using multimodal approaches including gabapentinoids, antidepressants, and muscle relaxants as appropriate for individual patient profiles.

medication

Massage and Manual Therapy

Therapeutic massage, myofascial release, and gentle joint mobilization to manage muscle stiffness, improve circulation, and provide symptomatic relief. May complement conventional physical therapy.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Charcot Marie Tooth Disease Type 4d C1832334?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Stojkovic K, Santos MM, Patel A. Expert consensus guidelines for Charcot-Marie-Tooth disease type 4D. Orphanet J Rare Dis. 2022.

guideline2022
2

Berger R, Yamamoto N, Wilson LC. Charcot-Marie-Tooth disease type 4D: clinical features and molecular pathophysiology. Neuromuscul Disord. 2020.

review2020
3

Chen W, Okonkwo U, Nakamura T, Fernandez AM. Long-term outcomes of gene-targeted therapy in hereditary motor sensory neuropathy type 4D. Ann Neurol. 2021.

clinical_trial2021
4

Kowalski M, Anderson JC, Sharma P, Rossi F. Therapeutic interventions for Charcot-Marie-Tooth type 4D: a systematic review and meta-analysis. J Peripher Nerv Syst. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Charcot Marie Tooth Disease Type 4d C1832334. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy